Advertisement

Organisation › Details
ArchiMed (Group)
Founded by Denis Ribon, previously Global Head of Healthcare at 3i, and his fellow Managing Partners, Vincent Guillaumot – another former 3i healthcare executive – and Robin Filmer-Wilson, a former 3i healthcare co-investor, ArchiMed is an independent private equity team 100% dedicated to the healthcare sector in Europe. The Managing Partners are currently investing from the €150 million Med 1 fund. The ArchiMed team also includes Operating Partner Loïc Kubitza, previously a Leader at PwC’s Healthcare and Life Sciences Practice, and Operating Partner Christoph Böhmer, formerly a McKinsey partner and Managing Director of €1 billion-in-revenues cardiovascular leader Biotronik. ArchiMed invests in all healthcare sectors, targeting profitable, established European healthcare companies and investing between €5 million and €30 million per transaction. ArchiMed engages in both unleveraged growth investments and leveraged buyouts. In the last sixteen years, the ArchiMed team has invested more than €1 billion in 20-plus companies, achieving a total return of over 2.6 times invested capital. *
![]() |
Start | 2014-01-01 established |
![]() |
Industry | private equity |
Industry 2 | healthcare | |
![]() |
Person | Guillaumot, Vincent (ArchiMed 2014 Partner + Co-Founder before JS Bio) |
Person 2 | Ribon, Denis (ArchiMed 201609 Founder + Managing Director before 3i 200904 Head European Healthcare) | |
![]() |
Region | Lyon |
Country | France | |
Street | 2 place de Francfort | |
City | 69003 Lyon | |
Tel | +33-4-8111-35 33 | |
Address record changed: 2023-12-04 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2025-03-16 |
Advertisement

More documents for ArchiMed (Group)
- [1] ArchiMed SAS. (10/7/22). "Press Release: ArchiMed Invests in PlasmidFactory, a German Gene and Cell Therapy Specialist"....
- [2] ArchiMed SAS. (11/3/21). "Press Release: ArchiMed Buys Cube, an Innovative Provider of Membrane Protein Services for the Biopharma Research Market"....
- [3] ArchiMed SAS. (10/5/21). "Press Release: ArchiMed Backs Xpress Biologics, a Leading Provider of Plasmid DNA for Advanced Therapy Medicinal Products"....
- [4] Clean Cells SAS. (9/15/21). "Press Release: Clean Cells Invests over €13M in New Biopharmaceutical Production Site". Montaigu-Vendée, near Nantes....
- [5] ArchiMed SAS. (8/5/21). "Press Release: ArchiMed Closes MED III at €650 Million Hard Cap in Less than Two Months"....
- [6] ArchiMed SAS. (1/12/21). "Press Release: ArchiMed Buys Germany’s Zyto Group of Cancer Diagnostics Companies in Partnership with Owners and Management"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top